$33.37
0[0.00%]
Last update: 4:20PM Get Real Time Here
Kymera Therapeutics
(NASDAQ:KYMR)Kymera Therapeutics Stock (NASDAQ:KYMR), Insider Trading Activity
Kymera Therapeutics: Insider buying and selling updated today.
Shares Outstanding
61.358M%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 15, 2024 | Bruce Booth | -127.543K | $40.25 | -$5.13M | SELL | -13.65% | 806.697K | Mar 14 - Mar 15 | View | |
| Mar 13, 2024 | Atlas Venture Fund X LPATLAS VENTURE ASSOCIATES X LPAtlas Venture Associates X LLCAtlas Venture Opportunity Fund I LPAtlas Venture Associates Opportunity I LPAtlas Venture Associates Opportunity I LLC | 10% OWNER | -353.357K | $42.20 | -$14.91M | SELL | -29.89% | 828.83K | Mar 11 - Mar 13 | View |
| Mar 13, 2024 | Bruce Booth | -353.357K | $42.20 | -$14.91M | SELL | -29.89% | 828.83K | Mar 11 - Mar 13 | View | |
| Mar 04, 2024 | Jared Gollob | CHIEF MEDICAL OFFICER | 21.031K | $41.86 | -$139.97K | GRANT | 28.15% | 95.74K | Mar 01 - Mar 04 | View |
| Mar 04, 2024 | Bruce Jacobs | CHIEF FINANCIAL OFFICER | 27.316K | $41.86 | -$164.66K | GRANT | 23.75% | 142.351K | Mar 01 - Mar 04 | View |
| Feb 29, 2024 | Jared Gollob | CHIEF MEDICAL OFFICER | 0 | $23.54 | -$17.17K | SELL-OPTIONS | 0.00% | 74.709K | Feb 27 | View |
| Feb 21, 2024 | Jeffrey Albers | 0 | $24.70 | -$143.56K | SELL-OPTIONS | 0.00% | 0 | Feb 20 - Feb 21 | View | |
| Feb 09, 2024 | Jared Gollob | CHIEF MEDICAL OFFICER | 0 | $18.79 | -$1.54M | SELL-OPTIONS | 0.00% | 74.709K | Feb 09 | View |
| Jan 23, 2024 | Jeffrey Albers | 0 | $20.19 | -$197.07K | SELL-OPTIONS | 0.00% | 0 | Jan 23 | View | |
| Jan 05, 2024 | Ellen Chiniara | CHIEF LEGAL OFFICER | -3.295K | $22.58 | -$74.42K | SELL | -8.79% | 34.205K | Jan 04 | View |
| Nov 06, 2023 | BVF PARTNERS L PILBIOTECHNOLOGY VALUE FUND L PBVF I GP LLCBIOTECHNOLOGY VALUE FUND II LPBVF II GP LLCBiotechnology Value Trading Fund OS LPBVF Partners OS LtdBVF GP HOLDINGS LLCINCIL BVFMARK LAMPERT | DIRECTOR | 414.105K | $12.80 | $5.30M | BUY | ∞ | 294.632K | Nov 02 - Nov 03 | View |
| Mar 03, 2023 | Elaine Caughey | CHIEF BUSINESS OFFICER | 9.843K | $31.00 | -$22.13K | GRANT | 107.66% | 18.986K | Mar 01 - Mar 02 | View |
| Mar 03, 2023 | Jared Gollob | CHIEF MEDICAL OFFICER | 17.452K | $31.00 | -$40.23K | GRANT | 30.48% | 74.709K | Mar 01 - Mar 02 | View |
| Mar 03, 2023 | Bruce N Jacobs | CHIEF FINANCIAL OFFICER | 22.38K | $31.00 | -$42.47K | GRANT | 27.23% | 104.568K | Mar 01 - Mar 02 | View |
| Jan 13, 2023 | BVF PARTNERS L PILBIOTECHNOLOGY VALUE FUND L PBVF I GP LLCBIOTECHNOLOGY VALUE FUND II LPBVF II GP LLCBiotechnology Value Trading Fund OS LPBVF Partners OS LtdBVF GP HOLDINGS LLCINCIL BVFMARK LAMPERT | DIRECTOR | 41.007K | $30.51 | $1.25M | BUY | 1.95% | 2.146105M | Jan 11 - Jan 12 | View |
| Jan 13, 2023 | Bruce Booth | DIRECTOR | -126.474K | $30.22 | -$3.82M | SELL | -12.44% | 890.148K | Jan 11 - Jan 12 | View |
| Jan 13, 2023 | Atlas Venture Fund X LPATLAS VENTURE ASSOCIATES X LPAtlas Venture Associates X LLCAtlas Venture Opportunity Fund I LPAtlas Venture Associates Opportunity I LPAtlas Venture Associates Opportunity I LLC | 10% OWNER | -126.474K | $30.22 | -$3.82M | SELL | -12.44% | 890.148K | Jan 11 - Jan 12 | View |
| Dec 16, 2022 | Bruce Booth | DIRECTOR | -382.244K | $31.36 | -$11.99M | SELL | -29.40% | 917.811K | Dec 14 - Dec 15 | View |
| Dec 16, 2022 | Atlas Venture Fund X LPATLAS VENTURE ASSOCIATES X LPAtlas Venture Associates X LLCAtlas Venture Opportunity Fund I LPAtlas Venture Associates Opportunity I LPAtlas Venture Associates Opportunity I LLC | 10% OWNER | -382.244K | $31.36 | -$11.99M | SELL | -29.40% | 917.811K | Dec 14 - Dec 15 | View |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.